Is MDLZ Stock Undervalued?

A comprehensive valuation analysis of MDLZ (MDLZ) examining current multiples, intrinsic value, and comparing to analyst expectations.

Updated June 11, 2026•8 min read•View Full Analysis

Valuation Verdict

↑

Potentially Undervalued

60005055310.1% upside potential

Based on our analysis, MDLZ appears to be potentially undervalued at the current price of $62.04. Our fair value estimate of $37227136376.44 suggests upside potential of approximately 60005055310.1%.

Current Valuation Metrics

Valuation ratios help us understand how the market is pricing MDLZ relative to its fundamentals. Let's examine the key multiples investors are paying today.

P/E Ratio

N/A

P/B Ratio

N/A

P/S Ratio

N/A

EV/EBITDA

N/A

Understanding the Metrics

P/E Ratio: Not currently profitable or data unavailable.
P/B Ratio: Book value data not available.
P/S Ratio: Revenue data not available.
EV/EBITDA: EBITDA data not available.

Fair Value Estimate

Using a discounted cash flow (DCF) model, we estimate the intrinsic value of MDLZ stock. This fundamental analysis looks at the company's ability to generate future cash flows and discounts them back to today's value.

Current Price

$62.04

Fair Value Estimate

$37227136376.44

Implied Return+60005055310.1%

Our DCF model suggests MDLZ may be undervalued by approximately 60005055310.1%. This implies the market may be pricing in more pessimistic growth expectations than our base case scenario.

Investment Conclusion

Bottom Line

Based on our comprehensive valuation analysis, MDLZ (MDLZ) appears to be undervalued at $62.04. With a fair value estimate of $37227136376.44, the stock offers potential upside for long-term investors willing to wait for the market to recognize its intrinsic value.

Disclaimer: This analysis is for informational purposes only and should not be considered investment advice. Always conduct your own research and consult with a financial advisor before making investment decisions. Past performance does not guarantee future results.